OPALEYE MANAGEMENT INC. purchased 10.3% of their position (7.93K shares) of ETON PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $125.5K — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 6/12/2025ACC: 0001641172-25-014868
10% Owner
Since Mar 2020
+7.93K
Net shares
Net buyer
$125.5K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
7.93K acquired
Non-Derivative Transactions2
Common Stock, par value $0.001 per share
Indirect
Shares
+5K
Price / share
$15.82
Trade value
$79.12K
% of position
0.2%
6/10/2025
2.77M→2.77M
Common Stock, par value $0.001 per share
Indirect
Shares
+2.93K
Price / share
$15.82
Trade value
$46.36K
% of position
3.6%
6/10/2025
82.07K→85K
Total
Net shares
+7.93K
Net value
$125.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share Indirect | 6/10/2025 | P · Purchase | +5K | $15.82 | $79.12K | 0.2% | 2.77M | 2.77M |
| Common Stock, par value $0.001 per share Indirect | 6/10/2025 | P · Purchase | +2.93K | $15.82 | $46.36K | 3.6% | 82.07K | 85K |
| Total | +7.93K | $125.48K | ||||||
Derivative Transactions0
No derivative transactions reported